Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes

Abstract Aims/Introduction To define the target value for the percentage coefficient of variation for glucose (%CV) as a measure of glycemic variability (GV) in Chinese diabetes patients. Materials and Methods This retrospective study included 3,007 diabetes patients who underwent continuous glucose...

Full description

Bibliographic Details
Main Authors: Yifei Mo, Xiaojing Ma, Jingyi Lu, Yun Shen, Yufei Wang, Lei Zhang, Wei Lu, Wei Zhu, Yuqian Bao, Jian Zhou
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Journal of Diabetes Investigation
Subjects:
Online Access:https://doi.org/10.1111/jdi.13453
id doaj-4895f4512a4b47dab2e3f4d3f24f4ffd
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yifei Mo
Xiaojing Ma
Jingyi Lu
Yun Shen
Yufei Wang
Lei Zhang
Wei Lu
Wei Zhu
Yuqian Bao
Jian Zhou
spellingShingle Yifei Mo
Xiaojing Ma
Jingyi Lu
Yun Shen
Yufei Wang
Lei Zhang
Wei Lu
Wei Zhu
Yuqian Bao
Jian Zhou
Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes
Journal of Diabetes Investigation
Coefficient of variation
Continuous glucose monitoring
Glycemic variability
author_facet Yifei Mo
Xiaojing Ma
Jingyi Lu
Yun Shen
Yufei Wang
Lei Zhang
Wei Lu
Wei Zhu
Yuqian Bao
Jian Zhou
author_sort Yifei Mo
title Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes
title_short Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes
title_full Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes
title_fullStr Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes
title_full_unstemmed Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes
title_sort defining the target value of the coefficient of variation by continuous glucose monitoring in chinese people with diabetes
publisher Wiley
series Journal of Diabetes Investigation
issn 2040-1116
2040-1124
publishDate 2021-06-01
description Abstract Aims/Introduction To define the target value for the percentage coefficient of variation for glucose (%CV) as a measure of glycemic variability (GV) in Chinese diabetes patients. Materials and Methods This retrospective study included 3,007 diabetes patients who underwent continuous glucose monitoring for 3 days. Type 2 diabetes was divided into groups according to the received treatment: group 1, non‐insulinotropic agent (n = 138); group 2, insulinotropic agent (n = 761); group 3, basal insulin therapy (n = 100); group 4, premixed insulin (n = 784); and group 5, intensive insulin therapy (n = 612). Type 1 diabetes patients were included as group 6 (n = 612). %CV and percentage of time per day within, below (3.9mmol/L; TBR3.9) and above (10.0 mmol/L) the target glucose range (3.9–10.0 mmol/L) were computed. TBR3.9 ≥4% was defined as excessive hypoglycemia. Results Type 2 diabetes with a premixed or intensive insulin regimen had an increased %CV compared with those receiving oral therapy or basal insulin. The upper limit of %CV in group 1 was 33%, which was adopted as the threshold to define excessive GV. For each treatment group, the percentage of people with TBR3.9 ≥4% was significantly greater in the subgroup with %CV >33% than ≤33% (P < 0.001). In participants who achieved TBR3.9 <4%, the time per day spent within the target glucose range of 3.9–10.0 mmol/L > 70% and time per day above 10.0 mmol/L <25%, the 95th percentile of %CV was 32.70%. Further receiver operating characteristic curve analysis showed that the cut‐off values of %CV for predicting TBR3.9 ≥4% varied by the type of diabetes and glycated hemoglobin categories. Conclusions A %CV of 33% was set as the threshold for excess glucose variability in Chinese diabetes patients. Meanwhile, glycated hemoglobin and the type of diabetes should be considered for the goal‐setting of %CV.
topic Coefficient of variation
Continuous glucose monitoring
Glycemic variability
url https://doi.org/10.1111/jdi.13453
work_keys_str_mv AT yifeimo definingthetargetvalueofthecoefficientofvariationbycontinuousglucosemonitoringinchinesepeoplewithdiabetes
AT xiaojingma definingthetargetvalueofthecoefficientofvariationbycontinuousglucosemonitoringinchinesepeoplewithdiabetes
AT jingyilu definingthetargetvalueofthecoefficientofvariationbycontinuousglucosemonitoringinchinesepeoplewithdiabetes
AT yunshen definingthetargetvalueofthecoefficientofvariationbycontinuousglucosemonitoringinchinesepeoplewithdiabetes
AT yufeiwang definingthetargetvalueofthecoefficientofvariationbycontinuousglucosemonitoringinchinesepeoplewithdiabetes
AT leizhang definingthetargetvalueofthecoefficientofvariationbycontinuousglucosemonitoringinchinesepeoplewithdiabetes
AT weilu definingthetargetvalueofthecoefficientofvariationbycontinuousglucosemonitoringinchinesepeoplewithdiabetes
AT weizhu definingthetargetvalueofthecoefficientofvariationbycontinuousglucosemonitoringinchinesepeoplewithdiabetes
AT yuqianbao definingthetargetvalueofthecoefficientofvariationbycontinuousglucosemonitoringinchinesepeoplewithdiabetes
AT jianzhou definingthetargetvalueofthecoefficientofvariationbycontinuousglucosemonitoringinchinesepeoplewithdiabetes
_version_ 1721409750217785344
spelling doaj-4895f4512a4b47dab2e3f4d3f24f4ffd2021-06-02T01:02:41ZengWileyJournal of Diabetes Investigation2040-11162040-11242021-06-011261025103410.1111/jdi.13453Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetesYifei Mo0Xiaojing Ma1Jingyi Lu2Yun Shen3Yufei Wang4Lei Zhang5Wei Lu6Wei Zhu7Yuqian Bao8Jian Zhou9Department of Endocrinology and Metabolism Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai ChinaDepartment of Endocrinology and Metabolism Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai ChinaDepartment of Endocrinology and Metabolism Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai ChinaDepartment of Endocrinology and Metabolism Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai ChinaDepartment of Endocrinology and Metabolism Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai ChinaDepartment of Endocrinology and Metabolism Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai ChinaDepartment of Endocrinology and Metabolism Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai ChinaDepartment of Endocrinology and Metabolism Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai ChinaDepartment of Endocrinology and Metabolism Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai ChinaDepartment of Endocrinology and Metabolism Shanghai Clinical Center for Diabetes Shanghai Key Clinical Center for Metabolic Disease Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Shanghai ChinaAbstract Aims/Introduction To define the target value for the percentage coefficient of variation for glucose (%CV) as a measure of glycemic variability (GV) in Chinese diabetes patients. Materials and Methods This retrospective study included 3,007 diabetes patients who underwent continuous glucose monitoring for 3 days. Type 2 diabetes was divided into groups according to the received treatment: group 1, non‐insulinotropic agent (n = 138); group 2, insulinotropic agent (n = 761); group 3, basal insulin therapy (n = 100); group 4, premixed insulin (n = 784); and group 5, intensive insulin therapy (n = 612). Type 1 diabetes patients were included as group 6 (n = 612). %CV and percentage of time per day within, below (3.9mmol/L; TBR3.9) and above (10.0 mmol/L) the target glucose range (3.9–10.0 mmol/L) were computed. TBR3.9 ≥4% was defined as excessive hypoglycemia. Results Type 2 diabetes with a premixed or intensive insulin regimen had an increased %CV compared with those receiving oral therapy or basal insulin. The upper limit of %CV in group 1 was 33%, which was adopted as the threshold to define excessive GV. For each treatment group, the percentage of people with TBR3.9 ≥4% was significantly greater in the subgroup with %CV >33% than ≤33% (P < 0.001). In participants who achieved TBR3.9 <4%, the time per day spent within the target glucose range of 3.9–10.0 mmol/L > 70% and time per day above 10.0 mmol/L <25%, the 95th percentile of %CV was 32.70%. Further receiver operating characteristic curve analysis showed that the cut‐off values of %CV for predicting TBR3.9 ≥4% varied by the type of diabetes and glycated hemoglobin categories. Conclusions A %CV of 33% was set as the threshold for excess glucose variability in Chinese diabetes patients. Meanwhile, glycated hemoglobin and the type of diabetes should be considered for the goal‐setting of %CV.https://doi.org/10.1111/jdi.13453Coefficient of variationContinuous glucose monitoringGlycemic variability